Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,159.7
0.9 (0.03%)

 

  • STI Straits Times Index
    3,159.7
    0.9 (0.03%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,597.4
    1.1 (0.07%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,435.7
    -33.3 (-0.13%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,006.4
    7.2 (0.24%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,079.1
    34.6 (0.16%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,231.5
    -13.0 (-0.21%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,091.5
    11.2 (0.54%)
    Index delayed 20 minutes
  • XAO XAO
    6,839.0
    13.8 (0.20%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 900.5M
  • Value: 1,592.9M
  • Rise: 124
  • Fall: 142
  • Unch: 570

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Keppel DC Reit2.110+0.040
YZJ Shipbldg SGD1.000-0.050
HPH Trust USD0.168-0.006
ThaiBev0.895-0.010
Frasers Cpt Tr2.750+0.020
TEE Intl0.043-0.004
Mapletree Com Tr2.290+0.020
Rex Intl0.084-0.001
Mapletree Log Tr1.630+0.020
Golden Agri-Res0.245-

World Indices

World Indices
Name Last Change
Nasdaq 8,117.7 -65.2
HSI 26,435.7
HSCEI 10,375.6
Jakarta 6,231.5
Nikkei 225 22,079.1 +34.6
SSE Comp 3,006.4
Shanghai A 3,149.6
Shanghai B 273.3
PSE Comp 0.0
KOSPI 2,091.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

KURA ONCOLOGY INC KURA ONCOLOGY
Updated on 20 Sep 2019 (End of trading day)
Last (USD): 16.370 Change: -0.070 High: 16.710 Remarks: -
Change (%): -0.43 Low: 15.990
Open 16.420 Yesterday's Close 16.44
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,368,995 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.33688 Trailing EPS (USD) e -1.32671 NAV (USD) b 5.4535
PE a - Trailing PE f - Price / NAV b 3.0017
Dividend (USD) d - Cash In Hand (USD) g 2.7000 Issued & Paid-up Shares c 45,215,000
Dividend Yield (%) d - Price / Cash In Hand g 6.063 Treasury Shares h -
Beta - 75 Daysi -0.361 R-Squared - 75 Days(%)i 2.22 Market Cap (M) 740.170
Beta - 500 Daysi 0.087 R-Squared - 500 Days (%)i 0.11 Enterprise Value (M) 486.750
Piotroski F Score 2 Exchange Code KURA Par Value ( $ ) n.a.
52 Weeks Volatility (%) 48.32 Free Float (%) 88.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 05 Aug 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 06 Mar 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference KURA ONCOLOGY INC NASDAQ 740.170 - - 3.0017 -
Industry Biotechnology NASDAQ 2,236.499 127.686 98.428 5.1904 0.795
Local Peer AMGEN INC NASDAQ 118,105.115 14.070 14.841 10.9417 2.815
Local Peer GILEAD SCIENCES INC NASDAQ 84,117.609 15.420 14.126 3.7194 3.475
Local Peer CELGENE CORP NASDAQ 70,427.593 17.407 13.361 7.0070 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 45,783.074 21.839 20.670 9.0303 -
Local Peer ILLUMINA INC NASDAQ 45,506.790 55.093 48.515 10.5048 -
Local Peer BIOGEN INC NASDAQ 44,044.099 9.941 8.319 3.4003 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 32,514.441 13.302 15.713 3.3328 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 23,839.815 307.212 17.876 2.3456 -
Local Peer INCYTE CORPORATION NASDAQ 17,465.591 159.514 57.102 7.7722 -
Local Peer EXACT SCIENCES CORP NASDAQ 13,462.555 - - 17.5860 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 13,450.752 - - 4.5427 -
Local Peer SEATTLE GENETICS INC NASDAQ 12,497.551 - - 9.8265 -
Other Local Peers GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIO-TECHNE CORP (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), MODERNA INC (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), REPLIGEN CORP (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), FIBROGEN INC (NASDAQ), ALKERMES PLC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), XENCOR INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), INSMED INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ALECTOR INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VERACYTE INC (NASDAQ), OPKO HEALTH INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), INTREXON CORP (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), EPIZYME INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), OMEROS CORP (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), NEXTCURE INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), CORTEXYME INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), SYNTHORX INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), RETROPHIN INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MERUS B V (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), DERMIRA INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), AGENUS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), RESTORBIO INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), MEDICINOVA INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), ARDELYX INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), COMPUGEN (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), GERON CORP (NASDAQ), RECRO PHARMA INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), PDL BIOPHARMA INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), ATHERSYS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), AFFIMED N V (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), GLYCOMIMETICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), XOMA CORP (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), CHIMERIX INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), NANTKWEST INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SESEN BIO INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), SAVARA INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), VERASTEM INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ADURO BIOTECH INC (NASDAQ), ARAVIVE INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), TREVENA INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SYNLOGIC INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), INMUNE BIO INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), COHBAR INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), VERMILLION INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), IVERIC BIO INC (NASDAQ), EVOGENE LTD (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), BIOCARDIA INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ZAFGEN INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), HISTOGENICS CORP (NASDAQ), BIOCEPT INC (NASDAQ), SOLIGENIX INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), NOVELION THERAPEUTICS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), TOCAGEN INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), PRECIPIO INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), TROVAGENE INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), OPGEN INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SPHERIX INC (NASDAQ), NEURALSTEM INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ)
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer CSL ASX 106,428.763 39.669 39.669 14.2225 1.132
Global Peer AGILENT TECHNOLOGIES INC NYSE 24,129.220 76.358 22.509 5.0831 0.785
Global Peer SINO BIOPHARM HKEx 133,823.198 12.489 12.890 3.9315 0.688
Global Peer WUXI BIO HKEx 99,337.273 132.998 103.974 10.2256 -
Global Peer BEIGENE HKEx 61,755.402 - - 5.0871 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer GENSCRIPT BIO HKEx 32,661.585 196.417 - 9.2107 -
Global Peer 3SBIO HKEx 31,835.325 21.045 25.615 3.1378 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,634.696 42.021 - 2.6643 -
Other Global Peers FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), VIVA BIOTECH (HKEx), AVITA MEDICAL LTD (ASX), HAOHAI BIOTEC (HKEx), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ASCLETIS-B (HKEx), CKLIFE SCIENCES (HKEx), ARCUS BIOSCIENCES INC (NYSE), ESSEX BIO-TECH (HKEx), KADMON HLDGS INC (NYSE), NEXT SCIENCE LTD (ASX), LEE'S PHARM (HKEx), STARPHARMA HOLDINGS LIMITED (ASX), TELIX PHARMACEUTIC (ASX), 22ND CENTURY GROUP INC (NYSE American), DPHARMA (Bursa), PFENEX INC (NYSE American), ENZO BIOCHEM INC (NYSE), LINEAGE CELL THERAPEUTICS INC (NYSE American), UNI-BIO GROUP (HKEx), BBI LIFE SCI (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), RESAPP HEALTH LIMITED (ASX), CEL-SCI CORP (NYSE American), PHYLOGICA LIMITED (ASX), PORT (SET), SYNTHETIC BIOLOGICS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), IMMUTEP LTD (ASX), IMUGENE LIMITED (ASX), IBIO INC (NYSE American), CT ENTERPRISE (HKEx), REGENT PACIFIC (HKEx), ARMATA PHARMACEUTICALS INC (NYSE American), ORTHOCELL LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), BIOTRON (ASX), EXTRAWELL PHAR (HKEx), BIOSINO BIO-TEC (HKEx), ORAGENICS INC (NYSE American), RHINOMED LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), KAZIA THERAPEUTICS LIMITED (ASX), MEMPHASYS LTD (ASX), ISORAY INC (NYSE American), PROTEOMICS INTL LABORATORIES LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), BIONOMICS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), ADALTA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), REGENEUS LTD (ASX), Suntar Eco-City^ (SGX), IMMURON LIMITED (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), CELLMID LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NANOVIRICIDES INC (NYSE American), GENETIC TECHNOLOGIES (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), BIOXYNE LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), HAO WEN HLDGS (HKEx), BENITEC BIOPHARMA LTD (ASX), MEDIBIO LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), LIVING CELL TECHNOLOGIES (ASX), MGRC (Bursa), MEGASUN (Bursa), ACTINOGEN MEDICAL LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), QT Vascular (SGX), NOVITA HEALTHCARE LTD (ASX), AIM IMMUNOTECH INC (NYSE American), TBG DIAGNOSTICS LTD (ASX), CCP TECHNOLOGIES LTD (ASX), NANOLLOSE LTD (ASX), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), ALCHEMIA LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.340
+2.12 %
10 Days -+0.840
+5.41 %
20 Days -+0.560
+3.54 %
Medium Term Return 3 Months --3.020
-15.58 %
6 Months -+1.480
+9.94 %
1 Year --0.730
-4.27 %
Long Term Return 2 Years -+4.370
+36.42 %
3 Years -+9.370
+133.86 %
Annualised Return Annualised --
+32.73 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 10.200 - 21.420 Change From 1 Year Low +6.170 % Change From 1 Year Low (%) +60.49
Change From 1 Year High -5.050 % Change From 1 Year High (%) -23.58
2 Years Range 10.200 - 24.025 Change From 2 Years Low +6.170 % Change From 2 Years Low (%) +60.49
Change From 2 Years High -7.655 % Change From 2 Years High (%) -31.86
5 Years Range 2.500 - 24.025 Change From 5 Years Low +13.870 % Change From 5 Years Low (%) +554.80
Change From 5 Years High -7.655 % Change From 5 Years High (%) -31.86
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
20 Sep 2019 16.420 16.710 15.990 16.370 1,368,995 -
19 Sep 2019 16.630 16.920 16.390 16.440 117,667 -
18 Sep 2019 16.470 16.760 16.280 16.610 179,786 -
17 Sep 2019 16.240 16.500 16.130 16.480 159,575 -
16 Sep 2019 15.990 16.510 15.980 16.350 186,766 -
13 Sep 2019 16.160 16.470 15.850 16.030 112,933 -
12 Sep 2019 16.440 16.440 16.010 16.140 104,773 -
11 Sep 2019 16.310 16.500 16.030 16.390 138,043 -
10 Sep 2019 15.460 16.500 15.300 16.310 175,018 -
09 Sep 2019 15.590 15.850 15.260 15.530 235,300 -
06 Sep 2019 16.110 16.580 15.460 15.530 273,214 -
05 Sep 2019 15.710 16.260 15.000 16.140 576,853 -
04 Sep 2019 15.150 15.250 14.990 15.240 136,703 -
03 Sep 2019 15.200 15.580 15.000 15.030 288,920 -
30 Aug 2019 15.300 15.520 14.930 15.180 193,224 -
29 Aug 2019 15.780 15.780 15.030 15.280 130,924 -
28 Aug 2019 15.220 15.815 15.220 15.620 151,280 -
27 Aug 2019 15.720 15.945 15.280 15.280 132,935 -
26 Aug 2019 15.960 15.975 15.410 15.630 241,544 -
23 Aug 2019 16.110 16.349 15.710 15.810 304,877 -
22 Aug 2019 16.920 16.940 16.230 16.250 187,173 -
21 Aug 2019 17.870 17.870 16.910 17.000 228,236 -
Summary
Current 2 Weeks
(09 Sep 2019 to 20 Sep 2019)
15.590 16.920 15.260 16.370 2,778,856 -
Previous 2 Weeks
(23 Aug 2019 to 06 Sep 2019)
16.110 16.920 15.260 15.530 2,430,474 -
4 Weeks from
(26 Jul 2019 to 22 Aug 2019)
19.340 19.710 15.260 16.250 4,717,767 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.